Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JW Asset Management is a New York-based SEC-registered investment adviser and asset management firm focused primarily on healthcare investing, with additional activity in cannabis and other sectors. The firm invests across both public and private equity markets and operates multiple hedge funds and private equity funds. JW Asset Management is led by founder, president, and chief investment officer Jason Wild, a pharmacist by training, and emphasizes sector expertise, industry relationships, and long-term value creation. While it is healthcare-focused, it is an investment firm rather than a drug developer, so it does not maintain a therapeutic pipeline in the biotech-company sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JW Asset Fund.